Pandemic Spurs Growth in Health Care Technology Venture Capital Deals

While the COVID-19 pandemic has devastated many sectors of the global economy, it has been a boon for the health care technology sector, which has seen a surge in venture capital (VC) deal-making during the first quarter of the year, according to financial data and information provider Preqin.

Demand for digitally accessible health care products and services has soared as a result of the global lockdown. With huge swaths of the public sheltering in place at home, governments worldwide have been lowering regulatory hurdles that will help increase investor interest in the sector.

Health care technology was already an area of interest to venture capital investors, with $19 billion in deals completed in the sector in 2019, and a record $20 billion in 2018, but the COVID-19 pandemic significantly heightened that interest. Between January and March the total value of global venture-backed health care technology or “health-tech” deals increased 76% compared with the first quarter of 2019 to $8.2 billion. That’s a 25% increase in aggregate deal value compared with the fourth quarter of 2019, and the highest quarterly total on record.

“Remote consultations, prescription delivery, digital therapeutic and wellness classes—demand for next-generation health care solutions has boomed,” Christopher Beales, Preqin’s private equity spokesperson, said in a statement. “Startups and investors are jumping to try and meet that need, and a sector that was already expanding has been given a real shot of adrenaline.”

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news. 

Health care technology deal activity has been dominated by North America, which makes up 56% of the total number of deals, followed by Europe, which comprises 21% of all deals, and Asia with 17%.

The largest venture-backed health-tech deal completed during the first quarter was the $285 million series E financing held by ClassPass Inc., a provider of access to fitness classes. The second largest deal during the quarter was the $250 million series D financing for ScriptDash Inc., a San Francisco-based digital pharmacy that trades under the brand name Alto.

“These deals underscore the growing investor appetite for consumer-focused, personalized, digitally accessible health and wellness solutions,” Beales wrote in a blog on Preqin’s website. “Digital technologies such as mobile internet are increasingly being deployed to provide consumers with fast, easy ways to look after their health.”

Deal-making in the sector has continued to rise during the second quarter, with another $3.2 billion in health-tech deals made since the start of April, and Preqin expects a new record for the sector will be set before the year is out. The firm also cites its April survey in which 36% of investors active in alternative assets polled said they are targeting health care-focused investment in 2020 because of COVID-19’s impact.

“This is likely to drive even greater interest in digital health innovations that can offer users on-demand health and wellness services—all at the touch of a button,” Beales said.

Illinois State Treasurer Pushes for Venture Capital Boost

Venture Capital Deals Set Record for 5th Straight Year

Tags: Christopher Beales, Coronavirus, COVID-19, Health Care, healthtech, Pandemic, Preqin, Venture Capital

The pandemic has kept the US Securities and Exchange Commission (SEC) busy tracking down and charging scammers who are using COVID-19 to swindle investors. The regulator has halted trading in dozens of stocks in connection with COVID-19, and has brought charges in several alleged coronavirus scams, including allegations of misleading claims, manipulative trading schemes, and other scams.

“As many of us are focused on supporting our families, friends, and neighbors during this difficult time, some fraudsters are seeking to use the COVID-19 crisis as a basis for investment scams,” Marc Berger, director of the SEC’s New York Regional Office, said in a statement.

The SEC has issued an investor alert about fraudulent scams related to COVID-19, which it updates periodically, and later this month the New York Regional Office will host an educational telephone town hall about avoiding scams related to COVID-19. Joining SEC officials at the town hall will be US Attorney for the District of New Jersey Craig Carpenito and Gerri Walsh, president of the Financial Industry Regulatory Authority (FINRA) Foundation.

The SEC’s Office of Investor Education and Advocacy and the Division of Enforcement’s Retail Strategy Task Force are also warning investors about the red flags that can indicate fraud relating to COVID-19.

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news. 

“We have become aware of a number of stock promotions, including online and through unsolicited phone calls, claiming that products or services of publicly traded companies can prevent, detect, or cure COVID-19, and that the stock of these companies will dramatically increase in value as a result,” the SEC said. “If you are considering investing in a company, especially in a microcap or penny stock, be skeptical of claims that products or services can prevent, detect, or treat COVID-19, or help to solve issues resulting from the current pandemic.”

Scammers are also promoting rumors on social media, on online bulletin boards, and in chat rooms. False claims also might concern companies converting operations to COVID-19-related support, or legislative relief packages and related industries that supposedly benefit from the crisis.

The regulator said false claims about a company’s products and services are sometimes part of a “pump-and-dump” scheme, and that microcap stocks may be particularly vulnerable to these because they often have limited public information, which can make it easier to spread false information and move the price of a stock to take advantage of the public.

Many investment frauds also involve unlicensed individuals or unregistered firms, so the SEC strongly recommends verifying that a seller is currently registered or licensed using the free search tools on Investor.gov.

In addition to luring victims looking to make money on investments, the SEC also warns that some COVID-19-related scams will attempt to appeal to an investor’s desire to help others by using charitable causes as a hook for investment scams. For example, they may pretend that your investment will provide financial support or medical treatment to people in need as a result of the COVID-19 pandemic and then steal your money instead.

The SEC said investors considering participating in an investment offered by a charity that claims to be a tax-exempt or “501(c)(3)” organization should check out the organization’s tax status on the Tax Exempt Organization Search on the IRS website. Even if a charity has 501(c)(3) status, this does not mean the investment is a legitimate opportunity—it still could be part of a fraudulent scheme, the SEC warns.